Athira Pharma, Inc. 已确认，其普通股将于1月12日（周五）在纳斯达克资本市场开始交易，并将采用新的股票交易代码。
此次交易代码的变更标志着公司发展的一个新阶段，预计将为市场参与者和投资者提供更清晰的公司标识。股票交易的相关具体信息，投资者可关注官方公告或交易所发布的通知。
Athira Pharma, Inc. 已确认，其普通股将于1月12日（周五）在纳斯达克资本市场开始交易，并将采用新的股票交易代码。
此次交易代码的变更标志着公司发展的一个新阶段，预计将为市场参与者和投资者提供更清晰的公司标识。股票交易的相关具体信息，投资者可关注官方公告或交易所发布的通知。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.